The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Notably for ValiRx, subsidiary Inaphaea BioLabs Ltd launched during the first half of 2023. It is part of ValiRx's translational contract research organisation and is based in Nottingham. Translational means that ValiRx focuses on enabling the translation of innovative science into clinical development.
"Following its launch, Inaphaea has continued to build the translational contract research organisation concept by developing collaborations with companies that provide complementary capabilities, such as Physiomics [PLC], Oncobone [Ltd] and, more recently, Agility Life Sciences [Ltd]. Their services, when aligned with the cell-based testing of Inaphaea, present a very compelling service offering to companies seeking to translate preclinical assets into clinical candidates, including ValiRx's own development pipeline
Should be interesting?
It has been a busy time for Inaphaea as we welcomed new faces and partnerships in preparation for the highly anticipated lab launch on 26 September.
And this too:
https://www.inaphaea.com/inaphaea-biolabs-secures-first-external-contract
Physiomics will receive a fee (capped at £6m) of 6% of any future net revenues that may be received by ValiRx relating to its commercialisation of VAL201 and its derivatives in any indication, including prostate cancer, endometriosis and treatment for Coronavirus infection. Eligibility for part of this fee will be conditional on completion of an agreed programme of work by Physiomics that builds on the work already carried out under the 2011 agreement. This programme of work will start on 15 February 2021 and is required to be completed by 15 November 2021. In recognition of the collaborative nature of this new agreement, Physiomics will also be offered a seat on the ValiRx scientific advisory board.
Thought this looks interesting fwiw
https://www.valirx.com/news/meet-valirx-scientific-advisory-board
So you are now saying there are big trades, nice one Dave
It's a volatile stock there will be big buys and big sales all day long
Hey Davey, is that another black trade I see? 640k?
See us continue to edge on towards a sensible MCAP level..
Good day here good to see .Also HE1 money starting to move in there .
Don’t lie Tricky, you must be a broker ;) ;)
Another one of those 7k buys just shown up from 9.03 am there is a fair few and in terms of the trades here id say they are meaty
WHAT!!!! you are a complete rocket mate!
Where did I say anything about an order book? The trades have been transacted and are listed for everyman and there dog to see.
I think you lot are deluded. I HOLD PYC I took almost a 100% big slice from my 1p shares last week and left a small amount to ride. I just like to question how day traders and well known ones like Ria/Laura/GB can post highly misleading posts and get away with it. "meaty orders" ....how does he know if there's any meaty orders on the book...is he a market maker or a broker and if he is he is not allowed to post on a forum so he is clearly posting false info on a stock
Funny that, he also turns up exactly as the SP starts reversing back to the upside again. Desperate derampers showing their true colours.
Amen Chiddy!
Quite a few 8-10k blocks early doors, they won’t give you anymore than that as I tried a few dummies.
Nice of you to appear doubting my findings, usually a good sign. Are you related to Petro investor? Seems strange he’s absent and you appear?
Ohhhh Davey is here. Deramp'o'clock people. The chunky orders are obvious if you take a look at the list of trades pal. Lots in the 5-12k range which is the largest amount you can get hold of with constant NT and low free-float.
"meaty orders"...where are all these meaty orders then GB ?
There’s a lot on radio 4 lately about controlling accurate drug dose for cancer therapies.
Have a nice day new uncle, I’ll be in and out enjoying g some golf and sun. Let the day traders sit indoors and sweat, we are in and it’s only going one way!
Some meaty orders showing now, very difficult to buy anything larger than those values!
Gordanbennett1 agree its still oversold from last year....topped holdind for 5p plus mcap is still low..imo
Looks like weak hands being flushed out GB
Demand is high this am and with the limited free float the Mm will have to mug a few punters before they take it to 3 and beyond. They have however laid down the marker and early doors too! Sit tight, grab a coffee and catch some early sun